Mettler-Toledo Stock Price, News & Analysis

Mettler-Toledo International reported strong second quarter results for 2021, with sales up 34% to $924.4 million. Adjusted EPS rose 53% to $8.10, while GAAP EPS increased to $7.85 from $5.22. Growth was broad-based across regions: 31% in the Americas, 34% in Europe, and 37% in Asia/Rest of World. Despite robust demand, management cautioned about future challenges due to COVID-19 and global supply chain issues. The outlook for 2021 projects local currency sales growth of 15% and adjusted EPS between $32.60 and $32.90.

Mettler-Toledo International Inc. (NYSE: MTD) announced a conference call on July 29, 2021, at 5:00 p.m. ET to discuss its quarterly results. A live webcast will be available on the Company’s investor relations website, with a replay accessible until August 2, 2021. Mettler-Toledo is a global leader in precision instruments and services, recognized for its innovation across various industries including life sciences and food. The company maintains a strong market presence, operating in over 140 countries and holding a leading position in numerous markets.

Mettler-Toledo International Inc. (NYSE:MTD) will present at the Jefferies Virtual Healthcare Conference on June 3, 2021, at 3:00 p.m. ET. Investors can access the live webcast on the company's investor relations page, with a replay available for seven days. Mettler-Toledo is a top global supplier of precision instruments, holding leading market positions across various sectors including life sciences and food, with a robust sales network operating in over 140 countries. The company aims to maintain strong financial performance through proven growth strategies.

Mettler-Toledo International announced its participation in the 2021 UBS Global Healthcare Virtual Conference on May 26, 2021, at 12:00 p.m. Eastern Time. The company will provide a live webcast of its presentation, accessible via the investor relations page on its website. Mettler-Toledo is recognized as a global leader in precision instruments and services, holding top positions in key industries such as life sciences and food. With a broad sales network in over 140 countries, the company maintains a strong focus on growth and operational excellence.

Mettler-Toledo International reported a strong start to 2021, with 24% increase in sales compared to last year, totaling $804.4 million. The company achieved an EPS of $6.32, up from $4.03 last year, and an adjusted EPS of $6.56, a 64% increase. Sales growth was driven by robust demand across regions, particularly in China, with local currency sales growth projected at 10%-12% for 2021. Despite this, management cautioned about ongoing uncertainties affecting market conditions due to COVID-19.

Mettler-Toledo International Inc. (NYSE:MTD) announced its participation in the BofA Securities 2021 Virtual Healthcare Conference, scheduled for May 12, 2021, at 12:30 p.m. ET. A live webcast will be accessible via the investor relations section of the Company's website, with a replay available for seven days. Mettler-Toledo is a prominent global provider of precision instruments and services, recognized for its leadership in R&D, quality control, and manufacturing across various industries.

Mettler-Toledo International Inc. (NYSE: MTD) will host a conference call on May 6, 2021, at 5:00 p.m. Eastern Time to discuss its quarterly results. Investors can access the live webcast at www.mt.com/investors, with a replay available until May 10, 2021. Mettler-Toledo is a leading global supplier of precision instruments and services, holding strong market positions across various industries, including life sciences and chemicals. The company operates in over 140 countries and is recognized for its innovation and extensive sales network.

Mettler-Toledo International (NYSE: MTD) has successfully acquired PendoTECH, a pioneer in single-use sensors and monitoring systems for bioprocess applications. The acquisition includes an initial payment of $185 million plus contingent consideration up to $20 million. This strategic move enhances Mettler-Toledo's offerings in the bioprocess market, expanding its sensor capabilities, particularly with pressure sensors, which are critical in bioproduction. The integration aims to boost cross-selling and global reach, capitalizing on the growing bioprocessing market.

Mettler-Toledo International Inc. (NYSE:MTD) will present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on February 24, 2021, at 10:45 a.m. ET. The event can be accessed through the investor relations page on the company's website, with a replay available for seven days. Mettler-Toledo is a global leader in precision instruments and services, holding significant market positions across various industries, including life sciences and food. The company has a strong financial performance history and a wide sales network operating in over 140 countries.